Rockland Immunochemicals, a Leader in Antibodies and Assay Development Services, Launches Content-Rich e-Commerce Website

Published: Mar 12, 2012

Gilbertsville, PA. March 12, 2012 – Rockland, a leader in the production of the antibodies and assays for the study of cell signaling events, announces the launch of a new, collaborative web site designed for scientific information exchange and customer ease of use.

The company’s antibody e-commerce site facilitates academic and industry collaborations and provides a platform for thought leaders in the life science industry. The new platform provides researchers relevant information prior to ordering antibodies or contract research.

“Rockland’s technology platform brings together and leverages the distinct perspectives of scientists from academia, non-profit organizations and the private sector to foster multi-institutional and trans-disciplinary partnerships,” commented James Fendrick, CEO and President of Rockland. “The global biological research market is valued at 30 billion with a CAGR of 8.4% over the next 5 years. Facilitating scientific collaboration and customer input to provide researchers with the most relevant choice of product is Rockland’s primary goal”

In 2012, Rockland celebrates 50 years of service to the life science industry, providing scientists with antibodies and antibody based tools for cancer, cell biology, cell signaling and neuroscience research that are guaranteed to give predictable, repeatable results.

About Rockland

For 50 years, Rockland has supported the biopharma and diagnostic industries with antibodies and antibody based tools™ for basic research, assay development, and preclinical studies. With manufacturing facilities in Pennsylvania, Rockland is engaged in the development of new technologies for the production of antibodies for western blotting, immunohistochemistry (IHC), immunofluorescence microscopy, ELISA and FLOW cytometry. More information about Rockland products and services can be found at the company’s web site at

For additional information regarding this announcement, please contact:

Tabitha Patrick

Communications, Rockland Immunochemicals Inc.

Phone: 610.369.1008


Like Rockland On Facebook

Back to news